Herein, we comprehensively evaluate the expression and activation of TAZ and YAP in over 150 sarcomas, explore the relative contribution of TAZ and YAP to sarcomagenesis, as well as the viability of inhibiting the TAZ/YAP-TEAD4 complex in sarcomas. This evidence concerns the gene WWTR1 and sarcoma.